Soligenix (SNGX) Gross Profit Growth (1y) (2011 - 2023)
Soligenix (SNGX) Gross Profit Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 63.51% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 126.09% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 33.01% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 57.16% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -99.98% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 351.57% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -89.89% |
| Sep 30, 2023 | -45.51% |
| Jun 30, 2023 | -35.17% |
| Mar 31, 2023 | -67.51% |
| Dec 31, 2022 | 476.16% |
| Sep 30, 2022 | 84.12% |
| Jun 30, 2022 | 236.31% |
| Mar 31, 2022 | 279.86% |
| Dec 31, 2021 | -49.63% |
| Sep 30, 2021 | -91.03% |
| Jun 30, 2021 | -92.60% |
| Mar 31, 2021 | -73.45% |
| Dec 31, 2020 | -19.08% |
| Sep 30, 2020 | -23.24% |
| Jun 30, 2020 | -69.02% |
| Mar 31, 2020 | -56.17% |
| Dec 31, 2019 | -22.74% |
| Sep 30, 2019 | 100.84% |
| Jun 30, 2019 | 97.59% |
| Mar 31, 2019 | 53.97% |